CARNIO, Simona
 Distribuzione geografica
Continente #
NA - Nord America 951
EU - Europa 673
AS - Asia 646
AF - Africa 34
OC - Oceania 20
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.340
Nazione #
US - Stati Uniti d'America 865
CN - Cina 280
IT - Italia 173
IE - Irlanda 128
JP - Giappone 108
FR - Francia 80
CA - Canada 67
IN - India 62
GB - Regno Unito 53
DE - Germania 46
VN - Vietnam 31
ID - Indonesia 27
RU - Federazione Russa 24
NL - Olanda 22
AU - Australia 20
BE - Belgio 20
ES - Italia 20
KR - Corea 18
TW - Taiwan 18
HK - Hong Kong 17
AT - Austria 16
IR - Iran 16
MX - Messico 14
PL - Polonia 13
SG - Singapore 12
UZ - Uzbekistan 12
CH - Svizzera 11
IL - Israele 10
JO - Giordania 10
RO - Romania 10
TR - Turchia 10
ZA - Sudafrica 10
CZ - Repubblica Ceca 9
BR - Brasile 7
NG - Nigeria 7
SE - Svezia 7
GR - Grecia 6
NO - Norvegia 6
GT - Guatemala 5
PH - Filippine 5
TN - Tunisia 5
DK - Danimarca 4
EG - Egitto 4
FI - Finlandia 4
MK - Macedonia 4
TH - Thailandia 4
AL - Albania 3
HU - Ungheria 3
KE - Kenya 3
PE - Perù 3
SA - Arabia Saudita 3
SI - Slovenia 3
CL - Cile 2
EU - Europa 2
HR - Croazia 2
ML - Mali 2
MY - Malesia 2
RS - Serbia 2
UA - Ucraina 2
UG - Uganda 2
A1 - Anonimo 1
CD - Congo 1
CO - Colombia 1
LT - Lituania 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 2.340
Città #
Dublin 126
Houston 87
Fairfield 70
Santa Cruz 42
Ann Arbor 41
Beijing 29
Ashburn 27
Buffalo 25
Woodbridge 25
Shanghai 24
Torino 24
Tokyo 23
Wilmington 23
Cambridge 22
Nanjing 22
Guiyang 19
Turin 18
Hangzhou 17
Dong Ket 15
Duncan 15
London 15
Seattle 15
Los Angeles 14
New York 14
Wuhan 14
Chicago 13
Vienna 13
Bukhara 12
Taipei 12
Toronto 12
Walnut Creek 12
Hefei 11
Milan 11
Saint-Michel 11
Bengaluru 10
Changchun 10
Chengdu 10
San Francisco 10
Indianapolis 9
Mountain View 9
San Diego 9
Amman 8
Fontenay-sous-bois 8
Guangzhou 8
Pisa 8
Rome 8
Warsaw 8
Amsterdam 7
Las Vegas 7
Ottawa 7
Paris 7
San Jose 7
Bartlesville 6
Montreal 6
Osaka 6
Padova 6
Seoul 6
Taintignies 6
Takamatsu 6
University Park 6
Brussels 5
Central District 5
Changsha 5
Guatemala City 5
Hebei 5
Jinan 5
Lake Forest 5
Marseille 5
Mumbai 5
Naaldwijk 5
New Delhi 5
Phoenix 5
Singapore 5
Ōtemachi 5
Barcelona 4
Boardman 4
Bologna 4
Central 4
Dki Jakarta 4
Hanoi 4
Helsinki 4
Istanbul 4
Jakarta 4
Krakow 4
Machida 4
Menlo Park 4
Moscow 4
Otemachi 4
Philadelphia 4
Richland 4
Suri 4
Taiyuan 4
Vincennes 4
Andover 3
Asahikawa 3
Asti 3
Autelbas 3
Birmingham 3
Bristol 3
Brüttisellen 3
Totale 1.238
Nome #
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics, file e27ce431-d7ce-2581-e053-d805fe0acbaa 510
Extending survival of stage IV non-small cell lung cancer., file e27ce428-c395-2581-e053-d805fe0acbaa 448
Osimertinib-induced Cardiac Dysfunction in EGFRMutated Lung Cancer: A Case Series of Five Patients, file e27ce42d-b323-2581-e053-d805fe0acbaa 324
Black Hairy Tongue After Immune Checkpoint Inhibitors in NSCLC: A Case Report and Review of the Literature, file e27ce432-2438-2581-e053-d805fe0acbaa 272
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave, file e27ce431-36e2-2581-e053-d805fe0acbaa 189
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma, file e27ce435-141e-2581-e053-d805fe0acbaa 137
Fatigue in lung cancer patients: symptom burden and management of challenges., file e27ce42b-32b3-2581-e053-d805fe0acbaa 101
Prognostic and predictive biomarkers in early stage non-small cell lung cancer: Tumor based approaches including gene signatures, file e27ce428-d55d-2581-e053-d805fe0acbaa 94
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG, file e27ce431-1ad1-2581-e053-d805fe0acbaa 93
Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer, file e27ce428-e271-2581-e053-d805fe0acbaa 76
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features, file e27ce432-0a06-2581-e053-d805fe0acbaa 76
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%, file e27ce435-25e5-2581-e053-d805fe0acbaa 41
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer, file da5de55f-f3c4-4f0c-9ea1-6482648974b4 13
Pericarditis during chemoimmunotherapy for non–small cell lung cancer: an adverse event to prevent and recognise, file e27ce432-2725-2581-e053-d805fe0acbaa 8
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counseling, file 57624aad-e522-427a-8cac-77c6916023b3 6
Pulmonary Arterial Hypertension in ALK Receptor Tyrosine Kinase–Positive Lung Cancer Patient: Adverse Event or Disease Spread?, file e27ce42d-e9b4-2581-e053-d805fe0acbaa 5
Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non-Small-cell Lung Cancer: A Multicenter Italian Survey., file e27ce42c-26ec-2581-e053-d805fe0acbaa 3
A challenge to overcome: the maintenance of the global quality of life in patients with advanced or metastatic non-small cell lung cancer, file e27ce42a-d27d-2581-e053-d805fe0acbaa 2
Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey., file e27ce42c-a428-2581-e053-d805fe0acbaa 2
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%, file e27ce434-99bf-2581-e053-d805fe0acbaa 2
Moving from histological subtyping to molecular characterization: new treatment opportunities in advanced non-small-cell lung cancer, file e27ce428-e652-2581-e053-d805fe0acbaa 1
Totale 2.403
Categoria #
all - tutte 3.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201944 0 0 0 0 0 0 0 0 0 0 28 16
2019/2020116 9 11 7 20 12 14 10 6 10 4 3 10
2020/2021193 6 21 7 12 7 10 8 13 13 14 24 58
2021/20221.156 114 86 71 159 151 76 89 75 86 83 94 72
2022/2023576 33 68 80 73 67 48 44 47 41 35 32 8
2023/2024158 5 19 13 18 20 22 21 17 2 18 3 0
Totale 2.403